1
|
Accomasso F, Actis S, Minella C, Rosso R, D’Alonzo M, Ponzone R, Bounous V, Biglia N. P147 Clinical, pathological, and prognostic features of male breast cancer. A multicenter study. Breast 2023. [DOI: 10.1016/s0960-9776(23)00264-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
|
2
|
Mennuni G, Fontana M, Perricone C, Nocchi S, Rosso R, Ceccarelli F, Fraioli A. A meta-analysis of the effectiveness of mud-bath therapy on knee osteoarthritis. Clin Ter 2021; 172:372-387. [PMID: 34247222 DOI: 10.7417/ct.2021.2343] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Objective Osteoarthritis (OA) results from loss of cartilage in-tegrity in association with changes to the structure of the entire joint. Treatment of OA is based on different pharmaceutical and no phar-maceutical approaches and the latter include the use of spa-therapy. The biological effects of mud-bath therapy are mainly secondary to heat stimulation and to physic-chemical properties of mineral waters and mud-packs. Mud-bath therapy likely exerts its effects modulating several cytokines and other molecules involved in inflammation and cartilage degradation. Our aim was to perform an updated meta-analysis of the effectiveness of the mud-bath therapy on knee osteoarthritis and briefly to discuss the mechanisms of action of this treatment. Materials and Methods A MEDLINE on PubMed for articles on knee OA and spa therapy published from 1995 through up to April 2019 was performed. Then, we checked the Cochrane Central Register of Controlled Trials to find additional references included up to April 2019. Articles were included if in accordance with the eligibility cri-teria. Sample size and effect sizes were processed with the MedCalc software package. Results Twenty one studies met the inclusion criteria and were included in meta-analysis. We examined WOMAC Index and VAS pain. We found significant improvements in function scores and painful symptoms after mud-bath therapy in patients with knee joint osteoarthritis. Conclusions Spa therapy is a non-drug treatment modalities, non invasive, complication-free, and cost-effective alternative modality for the conservative treatment of knee osteoarthritis. It cannot substitute for conventional therapy but can integrated or alternated to it. Treatment with mud-bath therapy may relieve pain, stiffness and improve functio-nal status in patients with knee OA.
Collapse
Affiliation(s)
- G Mennuni
- UOC Internal Medicine, Medical Therapy and Thermal Medicine - Specialization School in Thermal Medicine, Department of Clini-cal Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Umberto I Polyclinic University Hospital, Rome, Italy
| | - M Fontana
- UOC Internal Medicine, Medical Therapy and Thermal Medicine - Specialization School in Thermal Medicine, Department of Clini-cal Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Umberto I Polyclinic University Hospi-tal, Rome, Italy
| | - C Perricone
- Rheumatology Section - Department of Medicine, University of Perugia, Perugia, Italy
| | - S Nocchi
- UOC Internal Medicine, Medical Therapy and Thermal Medicine - Specialization School in Thermal Medicine, Department of Clini-cal Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Umberto I Polyclinic University Hospital, Rome, Italy
| | - R Rosso
- UOC Internal Medicine, Medical Therapy and Thermal Medicine - Specialization School in Thermal Medicine, Department of Clini-cal Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Umberto I Polyclinic University Hospital, Rome, Italy
| | - F Ceccarelli
- UOC Rheumatology - Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Policlinico Umberto I University Hospital, Rome, Italy
| | - A Fraioli
- UOC Internal Medicine, Medical Therapy and Thermal Medicine - Specialization School in Thermal Medicine, Department of Clini-cal Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Umberto I Polyclinic University Hospital, Rome, Italy
| |
Collapse
|
3
|
Compagni C, Salvi V, Corulli M, Rosso R, Gramaglia C. Clozapine-induced eosinopenia correlates with high drug serum levels: A case report. Asian J Psychiatr 2019; 43:83-84. [PMID: 31100604 DOI: 10.1016/j.ajp.2019.04.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Revised: 04/14/2019] [Accepted: 04/22/2019] [Indexed: 12/16/2022]
Affiliation(s)
- C Compagni
- Maternal and Child Department, S.C. of Child and Adolescent Neuropsychiatry Nord, ASL Città di Torino, Torino, Italy.
| | - V Salvi
- Department of Neuroscience, ASST Fatebenefratelli Sacco, Milano, Italy
| | - M Corulli
- Unit for Psychotic Disorders, Therapeutic Community "Il Porto" ONLUS, Moncalieri, TO, Italy
| | - R Rosso
- Unit for Psychotic Disorders, Therapeutic Community "Il Porto" ONLUS, Moncalieri, TO, Italy
| | - C Gramaglia
- Psychiatry Institute, Department of Translational Medicine, Università del Piemonte Orientale, SC Psychiatry, AOU Maggiore della Carità, Novara, Italy
| |
Collapse
|
4
|
Pepe A, Pistoia L, Giunta N, De Marchi D, Rosso R, Carrai V, Bulgarelli S, Giovangrossi P, Righi R, Tudisca C, Positano V, Meloni A. P3706The strong link between pancreas and heart in thalassemia major. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3706] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Pepe
- Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
| | - L Pistoia
- Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
| | | | - D De Marchi
- Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
| | - R Rosso
- Ospedale “Ferrarotto” - Azienda Ospedaliero-Universitaria Policlinico “Vittorio Emanuele”, Catania, Italy
| | - V Carrai
- Azienda Ospedaliero - Universitaria Careggi, Firenze, Italy
| | | | | | - R Righi
- Ospedale del Delta, Lagosanto (FE), Italy
| | | | - V Positano
- Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
| | - A Meloni
- Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
| |
Collapse
|
5
|
Benasso M, Ferro A, Bacigalupo A, Toma S, Vitriolo S, Rosso R, Merlano M. Analysis of 16 Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck: Implications for Treatment. Tumori 2018; 75:597-9. [PMID: 2617704 DOI: 10.1177/030089168907500617] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The present paper reports a retrospective analysis of 16 patients with distant metastases from squamous cell carcinoma of the head and neck observed in our Institute in the last 10 years. Nine patients out of 16 underwent chemotherapy (7 patients), chemotherapy and radiotherapy (1 patient), or an alternating chemo-radiotherapy regimen (1 patient). The remaining 7 patients were not considered for a palliative treatment because of a poor performance status. Two complete responses, 2 partial responses, 2 stable diseases and 3 progressions were observed, with an overall response rate of 44 %. Chemotherapy, when administrable, showed a temporary effectiveness, at least in patients with lung metastases. The combination of cisplatin and 5-fluorouracil seems to maintain the efficacy already shown in patients with locally relapsed disease.
Collapse
Affiliation(s)
- M Benasso
- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
| | | | | | | | | | | | | |
Collapse
|
6
|
Nobile MT, Vidili MG, Benasso M, Venturini M, Tedeschi M, Zunino F, Rosso R. A Preliminary Clinical Study of Cyclophosphamide with Reduced Glutathione Asc Uroprotector. Tumori 2018; 75:257-8. [PMID: 2773078 DOI: 10.1177/030089168907500313] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Reduced glutathione (GSH) has been reported to be an effective protector against cyclophosphamide-induced urotoxicity in experimental models, providing protection comparable to that of mesna. This paper describes our preliminary results of the clinical use of GSH in combination with cyclophosphamide. GSH was administered i.v. in two divided doses of 2.5 g, 15 min before and 30 min after escalating doses of cyclophosphamide ranging from 1.2 up to 1.6 g/m2 (1-h infusion). GSH was well tolerated and did not produce unexpected toxicity. The lack of bladder damage, including microscopic hematuria, supports the protective role of this thiol compound.
Collapse
Affiliation(s)
- M T Nobile
- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
| | | | | | | | | | | | | |
Collapse
|
7
|
Porcile G, Musso M, Boccardo F, Rosso R, Santi L. Combination Chemotherapy with Vinblastine, Bleomycin and Methotrexate in Dtic-resistant Metastatic Melanoma. Tumori 2018; 65:237-40. [PMID: 88784 DOI: 10.1177/030089167906500213] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.
Collapse
|
8
|
Brema F, Queirolo MA, Canobbio L, Bruzzi P, Puntoni R, Campora E, Rosso R. Hematologic Parameters during Treatment with High-Dose Medroxyprogesterone Acetate. Tumori 2018; 67:125-8. [PMID: 6454998 DOI: 10.1177/030089168106700208] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Blood clotting, platelet aggregation, complete blood count and lipid profile were evaluated in 12 postmenopausal patients with advanced breast cancer. Patients under treatment with high-dose MPA were considered not at risk for thomboembolic disease and were given MPA orally, 800 mg/day, for at least 3 months. Laboratory investigations were performed prior to treatment with MPA then once weekly during the first month and every 2 weeks during the following months. PTT, TEG, antithrombin III and platelet adhesiveness underwent statistically significant changes, tending towards hypercoagulability, although, on the average, they did not exceed the upper normal range. The authors conclude that a clinically relevant thrombotic activity cannot be attributed to MPA at the administered oral doses in the absence of additional risk factors.
Collapse
|
9
|
Nobile MT, Rosso R, Brema F, Cinquegrana A, Santi L. Phase II Study of Ifosfamide Combined with Mesna Uroprotection in Advanced Non-Small-Cell Lung Carcinoma and Other Solid Tumors. Tumori 2018; 70:433-7. [PMID: 6438851 DOI: 10.1177/030089168407000508] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Thirty six patients with advanced solid tumors (24 lung: 3 oat-cell, 14 squamous, 7 adenocarcinomas, 3 soft tissue sarcomas, 6 breast carcinomas; 1 seminoma; 2 ovarian adenocarcinomas) entered a phase II study of high-dose ifosfamide (IF) administered in combination with the uroprotective agent sodium 2-mercapto-ethane-sulfonate (Mesna). Fourteen patients had prior treatment; most patients with lung cancer (22/24) were previously untreated; all had measurable disease. The patients median age was 59 (range 31–74). IF was given at 1.8 g/m2 days 1–5 q 4 weeks. Mesna was given after each IF injection at 0, 4 and 8 h randomly, either i.v. (0.36 g/m2) or orally (0.72 g/m2). Twenty-four patients had ≥ 3 courses of therapy, 9 had 2 courses, and 3 had only 1 course; 129 courses were evaluated for toxicity. Mesna was given orally (17 patients, 57 courses) or i.v. (19 patients, 72 courses). The following side-effect were observed: no gross hematuria, microhematuria (14 courses), transitory mild proteinuria (34 courses), leukopenia grade I-II ECOG (26 courses), anemia grade I ECOG (31 courses), 1 case of pancytopenia, alopecia (31 patients), nausea (moderate, 33 courses; severe, 6 courses), vomiting (moderate, 17 courses; severe, 1 course). Five patients showed a partial response (1 oat-cell carcinoma, 2 with squamous lung cancer, 1 with ovarian carcinoma, 1 with breast carcinoma), 14 showed a minor response (2 patients with oat-cell carcinoma, 2 with lung adenocarcinoma, 5 with squamous lung cancer, 1 with seminoma, 1 with sarcoma, 1 with ovarian carcinoma), and 14 showed progression of disease (7 patients with squamous cell lung cancer, 4 with lung adenocarcinoma, 1 with sarcoma, 2 with breast carcinoma). Considering partial plus minor responses, ifosfamide produced some degree of tumor reduction (PR+MR) in 12/23 (52.1 %) lung cancer patients. The data reported support the conclusions that Mesna can prevent high-dose IF bladder toxicity, that IF is active in advanced solid tumors, including lung cancer, and that the IF + Mesna combination is a generally safe treatment procedure.
Collapse
|
10
|
Abstract
A clinical trial was undertaken to assess the feasibility of treatment with high-dose cisplatin on an outpatient basis. Eleven patients entered the study: 9 patients with squamous cell carcinoma of the head and neck, 1 patient with malignant melanoma of the skin, and 1 patient with breast cancer. All patients were pretreated. The chemotherapy scheme consisted of cisplatin, 60 mg/m2 for 3 consecutive days, every 4 weeks. We observed 5 partial responses, 4 stable diseases, and 1 progression of disease; 1 patient failed due to toxicity. The overall response rate was 45.4%. This treatment was associated with severe toxicity including nausea and vomiting, myelosuppression, neurotoxicity, nephrotoxicity and electrolyte disorders. Two patients died and 2 discontinued the treatment due to toxicity. In light of the incidence and severity of toxicity, this treatment should not be used as routine practice.
Collapse
Affiliation(s)
- M Merlano
- Dept. of Medical Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia
| | | | | | | | | | | |
Collapse
|
11
|
Repetto L, Chiara S, Pace M, Guido T, Bruzzone M, Oliva C, Murolo C, Conte PF, Rosso R. Prognostic Factors in Stage IV Ovarian Carcinoma Treated with Platinum-Based Regimens. Tumori 2018; 76:274-7. [PMID: 2195729 DOI: 10.1177/030089169007600313] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Eight factors were analyzed for prognostic significance in univariate analyses in a series of 76 women with stage IV ovarian carcinoma treated with combination chemotherapies including cisplatin or carboplatin. The clinical objective and pathologic complete response rates were 51.2% and 27.3%, respectively. Median overall survival and progression-free survival were 15 and 7 months, respectively. No variables reached statistical significance. Trends toward better survival were noted for grades 1 and 2 for the adriamycin-containing regimen. Using progression-free survival as an end point, significant prognostic factors included complete clinical or pathologic response. Our data confirm that the standard approach is unlikely to modify the clinical outcome of stage IV ovarian cancer. New treatment modalities including high-dose-intensity regimens and neo-adjuvant chemotherapy delivered before surgery could improve clinical results. Moreover, biologic characterization of ovarian tumors may provide information to design specifically targeted treatment.
Collapse
Affiliation(s)
- L Repetto
- Istituto Nazionale per la Ricerca sul Cancro, Oncologia Medica, Genova, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Merlano M, Conte PF, Tatarek R, Scarsi P, Barbieri A, Benedetti G, Rosso R. Ineffectiveness of 5-Fluorouracil and Cis-Platin as Second-Line Chemotherapy in Head and Neck Cancer. Tumori 2018; 70:267-9. [PMID: 6539969 DOI: 10.1177/030089168407000312] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Seventeen patients with heavily pretreated head and neck squamous cell carcinoma were submitted to a combination of 5-fluorouracil, 500 mg/m2 on days 1–4, and cis-platin, 50 mg/m2 on day 5, repeated every 21 days. Before administration of 5-fluorouracil, N5,N10-methyl-tetrahydrofolate, 200 mg/m2 i.v., was given. Only 1 partial response and 4 stable disease were observed, and the median survival of the entire group was 5 months. Although all patients had been heavily pretreated and a considerable percentage (6/17, 35.2 %) of these showed resistance to first-line therapy, this combination seems to be ineffective as second-line therapy in head and neck cancer.
Collapse
|
13
|
Mariani GL, Pennucci MC, Addamo G, Venturini M, Ardizzoni A, Rosso R. A Pilot Study of Mitomycin, Ifosfamide and Cisplatin as Outpatient Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer. Tumori 2018; 77:511-3. [PMID: 1666469 DOI: 10.1177/030089169107700612] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Twenty-one patients with advanced stage, non-small-cell lung carcinoma were treated with a chemotherapy regimen including: mitomycin (6 mg/m2), ifosfamide (3 g/m2), cisplatin (80 mg/m2). The regimen was administered on an outpatient basis. Two patients were lost to follow-up. Among the 29 patients evaluable for response we registered a response rate of 36.8 %; 36.8% of patients had stable disease, and 15.7 % progressed during treatment. Median duration was 8.7 months and median survival was 11 months. Toxicity was low and easily manageable on an outpatient basis.
Collapse
Affiliation(s)
- G L Mariani
- Divisione di Oncologia Medica, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
| | | | | | | | | | | |
Collapse
|
14
|
Baldini E, Gardin G, Giannessi P, Brema F, Camorriano A, Carnino F, Naso C, Pastorino G, Pronzato P, Rosso R, Rubagotti A, Torretta G, Conte PF. A Randomized Trial of Chemotherapy with or without Estrogenic Recruitment in Locally Advanced Breast Cancer. Tumori 2018; 83:829-33. [PMID: 9428917 DOI: 10.1177/030089169708300511] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The present phase III trial was carried out to verify whether a kinetic recruitment induced by low doses of diethylstilbes-trol (DES) could increase the killing efficacy of chemotherapy in patients with locally advanced breast cancer. One-hundred and seventeen untreated patients with locally advanced breast cancer (stage IIIA/IIIB) were randomized to receive 3 courses of primary chemotherapy consisting of cyclophosphamide (600 mg/m2 i.v.), doxorubicin (50 mg/m2 i.v.) and fluorouracil (600 mg/m2 i.v.) (CAF) on day 1, or DES-CAF (DES, 1 mg orally days 1-3, CAF on day 4). The courses were repeated every 3 weeks. The patients who achieved an objective response were submitted to mastectomy followed by 3 courses of CAF alternated with 3 courses of CMF (cyclophosphamide, 600 mg/m2 i.v.; methotrexate, 40 mg/m2 i.v.; fluorouracil, 600 mg/m2 i.v.), with or without DES. The two treatment arms were well balanced in terms of clinical and pathologic features. There was no significant difference in response rates to induction chemotherapy between the two treatment arms (objective response rate, 63.3% for CAF and 56.1% for DES-CAF). Median overall survival was 49 and 47 months and median progression-free survival was 24 and 21 months for CAF and DES-CAF patients, respectively. Toxicity was not significantly different in the two groups, with the exception of leukopenia: DES chemotherapy was significantly more myelotoxic than the standard treatment, which resulted in a significant reduction in the actual dose intensity. In spite of the attractive experimental evidence, we conclude that so far there is no clinical advantage in the combination of estrogen and chemotherapy. Further research is needed to investigate different schedules of chemotherapy and hor-mones, or to test the possibility of combining various mitogens.
Collapse
|
15
|
Abstract
Aminoglutethimide, a drug known to block adrenal steroidogenesis and peripheral aromatization of androgens to estrogens, has been found effective in the treatment of breast cancer. The drug has been used in our Institute to treat 71 consecutive metastatic breast cancer patients. Of 67 patients evaluable for response, 9 (13.4%) have achieved a partial response, 30 (44.7%) stable disease, and 28 (41.7%) progression of disease. Four patients were taken off the therapy because of drug-related toxicity.
Collapse
|
16
|
Abstract
A case of acute neurological toxicity was observed in a patient with a retroperitoneal fibromyxosarcoma treated with DTIC (NSC-45382), Adriamycin and Vincristine. The neurological symptoms started one hour after drug administration and rapidly declined with symptomatic therapy; no EEG and scintigraphic changes were detectable. The case is discussed in relation to central nervous system complications reported by other authors, following administration of DTIC and Adriamycin.
Collapse
|
17
|
Merlano M, Grimaldi A, Bonelli L, Tatarek R, Rosso R. Failure of Second-Line Therapy to Modify Survival in Relapsed Squamous Cell Carcinoma of the Head and Neck. Tumori 2018; 71:367-70. [PMID: 4049539 DOI: 10.1177/030089168507100408] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Between August 1979 and August 1984, 47 consecutive patients with recurrent squamous cell carcinoma of the head and neck entered one of three consecutive second-line treatments. Response rates with each treatment were very different (70 % vs 5.9 % vs 75 %), but there was no statistical difference in actuarial survival (survival: 30 % vs 29 % vs 20 %, respectively, at 260 days). In light of this observation, the efficacy of the second-line therapy appears doubtful and the survival of relapsing patients seems unrelated to the response achieved.
Collapse
|
18
|
Abstract
Six case reports are described which illustrate a uniform syndrome characterized by progressive dysphagia developing in postmenopausal breast cancer patients after a long disease-free interval following mastectomy. Literature cases are reviewed and treatment strategies are discussed. The authors recommend that, when possible, radiotherapy to the mediastinum and/or chemotherapy with dilation or positioning of an endoprothesis should be considered as the treatment of choice, whereas surgical intervention should be limited.
Collapse
|
19
|
Campora E, Chiara S, Bruzzi P, Scarsi P, Rosso R. The Antiemetic Efficacy of Methylprednisolone Compared with Metoclopramide in Outpatients Receiving Adjuvant CMF Chemotherapy for Breast Cancer: A Randomized Trial. Tumori 2018; 71:459-62. [PMID: 3904102 DOI: 10.1177/030089168507100508] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A randomized trial was performed comparing the antiemetic efficacy of methylprednisolone (MPN) and metoclopramide (MCP) in 60 breast cancer patients eligible for outpatient adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-FU (CMF). At the time of their first chemotherapy course patients were randomized to receive either MPN 375 mg or MCP 1 mg/kg both administered in 3 equal doses, IV just prior to chemotherapy and then IM 6 and 12 hours after treatment. Patients receiving MPN experienced significantly less nausea (p < 0.0005) and vomiting (p < 0.0005) and antiemetic protection was maintained in patients receiving multiple chemotherapy courses. Complete protection (0 emesis) was observed in 58 % of patients receiving MPN as compared with 20 % of patients treated with MCP (p < 0.005). The most frequent side effects were facial flush in 38 % of patients and somnolence in 15 % of patients receiving MPN and MCP, respectively. Complete protection from CMF-induced gastrointestinal side effects was observed in two-thirds of our patients receiving antiemetic MPN treatment. In these patients administration of the maximum cumulative CMF dose was possible without impairing their quality of life. MPN, at the dose and schedule reported, is an affective antiemetic drug suitable for use in breast cancer outpatients receiving adjuvant CMF therapy.
Collapse
|
20
|
Conte PF, Bruzzone M, Chiara S, Rosso R, Giaccone G, Carnino F, Guercio E, Ragni N, Foglia G, Bentivoglio G. Carboplatin (JM 8), Adriamycin and Cyclophosphamide (JAC) in Advanced Ovarian Carcinoma: A Pilot Study. Tumori 2018; 74:217-20. [PMID: 2453091 DOI: 10.1177/030089168807400217] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Eleven untreated patients with advanced ovarian cancer were studied for tolerance and response to combination treatment with fixed doses of adriamycin (45 mg/m2) and cyclophosphamide (600 mg/m2) + escalating doses of carboplatin. At the first dose level of carboplatin (200 mg/m2), toxicity was acceptable. With carboplatin at 300 mg/m2, severe hematologic toxicity was observed. The dose-limiting toxicity was leukopenia. Although carboplatin was administered without any hydration, no patient experienced renal toxicity. Eight objective responses were observed in 9 clinically evaluable patients. At second look surgery, 3 complete responses and 4 partial responses were documented. Polychemotherapy with JAC (carboplatin, 200 mg/m2, adriamycin, 45 mg/m2, and cyclophosphamide, 600 mg/m2) is administrable with acceptable toxicity.
Collapse
Affiliation(s)
- P F Conte
- Istituto Nazionale per la Ricerca sul Cancro, Genova
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Amicarella F, Muraro MG, Hirt C, Cremonesi E, Padovan E, Mele V, Governa V, Han J, Huber X, Droeser RA, Zuber M, Adamina M, Bolli M, Rosso R, Lugli A, Zlobec I, Terracciano L, Tornillo L, Zajac P, Eppenberger-Castori S, Trapani F, Oertli D, Iezzi G. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut 2017; 66:692-704. [PMID: 26719303 PMCID: PMC5529969 DOI: 10.1136/gutjnl-2015-310016] [Citation(s) in RCA: 124] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2015] [Revised: 11/11/2015] [Accepted: 11/30/2015] [Indexed: 12/12/2022]
Abstract
BACKGROUND The immune contexture predicts prognosis in human colorectal cancer (CRC). Whereas tumour-infiltrating CD8+ T cells and myeloid CD16+ myeloperoxidase (MPO)+ cells are associated with favourable clinical outcome, interleukin (IL)-17-producing cells have been reported to correlate with severe prognosis. However, their phenotypes and functions continue to be debated. OBJECTIVE To investigate clinical relevance, phenotypes and functional features of CRC-infiltrating, IL-17-producing cells. METHODS IL-17 staining was performed by immunohistochemistry on a tissue microarray including 1148 CRCs. Phenotypes of IL-17-producing cells were evaluated by flow cytometry on cell suspensions obtained by enzymatic digestion of clinical specimens. Functions of CRC-isolated, IL-17-producing cells were assessed by in vitro and in vivo experiments. RESULTS IL-17+ infiltrates were not themselves predictive of an unfavourable clinical outcome, but correlated with infiltration by CD8+ T cells and CD16+ MPO+ neutrophils. Ex vivo analysis showed that tumour-infiltrating IL-17+ cells mostly consist of CD4+ T helper 17 (Th17) cells with multifaceted properties. Indeed, owing to IL-17 secretion, CRC-derived Th17 triggered the release of protumorigenic factors by tumour and tumour-associated stroma. However, on the other hand, they favoured recruitment of beneficial neutrophils through IL-8 secretion and, most importantly, they drove highly cytotoxic CCR5+CCR6+CD8+ T cells into tumour tissue, through CCL5 and CCL20 release. Consistent with these findings, the presence of intraepithelial, but not of stromal Th17 cells, positively correlated with improved survival. CONCLUSIONS Our study shows the dual role played by tumour-infiltrating Th17 in CRC, thus advising caution when developing new IL-17/Th17 targeted treatments.
Collapse
Affiliation(s)
- F Amicarella
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - M G Muraro
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - C Hirt
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - E Cremonesi
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - E Padovan
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - V Mele
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | - V Governa
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland,Institute of Pathology, University of Basel, Basel, Switzerland
| | - J Han
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland,Department of General Surgery, Shanghai East Hospital, Tongji University, Shanghai, China
| | - X Huber
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland,Department of General Surgery, University Hospital Basel, Basel, Switzerland
| | - R A Droeser
- Department of General Surgery, University Hospital Basel, Basel, Switzerland
| | - M Zuber
- Department of Visceral Surgery, Kantonsspital Olten, Olten, Switzerland
| | - M Adamina
- Department of Visceral Surgery, Kantonsspital St Gallen, St. Gallen, Switzerland
| | - M Bolli
- Department of Visceral Surgery, St Claraspital, Basel, Switzerland
| | - R Rosso
- Department of Visceral Surgery, Ospedale Civico Lugano, Lugano, Switzerland
| | - A Lugli
- Institute of Pathology, University of Bern, Bern, Switzerland
| | - I Zlobec
- Institute of Pathology, University of Bern, Bern, Switzerland
| | - L Terracciano
- Institute of Pathology, University of Basel, Basel, Switzerland
| | - L Tornillo
- Institute of Pathology, University of Basel, Basel, Switzerland
| | - P Zajac
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| | | | - F Trapani
- Institute of Pathology, University of Basel, Basel, Switzerland
| | - D Oertli
- Department of General Surgery, University Hospital Basel, Basel, Switzerland
| | - G Iezzi
- Department of Biomedicine, Institute of Surgical Research, University of Basel, Basel, Switzerland
| |
Collapse
|
22
|
Wieczorowska-Tobis K, Suwalska A, Cylkowska-Nowak M, Kropinska S, Tobis S, Tapus A, Salatino C, van den Huevel H, Barattini P, Ghrissi M, Rosso R. P-390: Robots in the care for elderly – defining users requirements. Eur Geriatr Med 2015. [DOI: 10.1016/s1878-7649(15)30487-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
23
|
Kumar S, Lipton J, Nisbett A, Heck P, Rosso R, Sparks P. Consolidating lesions at sites of critical pulmonary-vein left atrial connections in addition to PVI significantly improves AF-free survival compared to PVI alone. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Kumar S, Lipton J, Nisbett A, Sutherland F, Heck P, Rosso R, Sparks P. Sites of acute and chronic pulmonary vein reconnection can be predicted during the index pulmonary vein isolation for paroxysmal AF. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
D'Urso L, Simone G, Rosso R, Collura D, Castelli E, Giacobbe A, Muto G, Comelli S, Savio D, Muto G. Benefits and shortcomings of superselective transarterial embolization of renal tumors before zero ischemia laparoscopic partial nephrectomy. Eur J Surg Oncol 2014; 40:1731-7. [DOI: 10.1016/j.ejso.2014.08.484] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2014] [Revised: 08/28/2014] [Accepted: 08/29/2014] [Indexed: 10/24/2022] Open
|
26
|
Viskin S, Adler A, Strasberg B, Guevara-Valdivia M, Baranchuk A, Rosso R. LONG QT SYNDROME COMPLICATING ATRIOVENTRICULAR BLOCK: ARRHYTHMOGENIC EFFECTS OF CARDIAC MEMORY. Heart Rhythm 2014. [DOI: 10.1016/j.hrthm.2014.09.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
27
|
Borroni G, Torti S, Pezzini C, Vassallo C, Rosso R, D'Ospina RM, Tomasini C, Brazzelli V. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation. GIORN ITAL DERMAT V 2014; 149:291-300. [PMID: 24819756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is characterized by an heterogeneous group of severe dermatologic manifestations and systemic involvement, due to several groups of medicaments. A series of 9 consecutive cases, observed from 2008 to 2013 in the Department of Dermatology, University of Pavia, is reported, all satisfying the clinical, hematological and systemic diagnostic criteria of DRESS. Clinically, 4 out of 9 patients had an urticarial and papular eruption, 2 an erythema-multiforme-like (EM-like) pattern, 2 erythroderma and 1 had an erythematous and macular reaction. Aim of the study was to describe the histopathologic features of DRESS and to trace a possible correlation between the four clinical recognized types of the syndrome and the histopathological patterns. Predominantly, a superficial perivascular lymphocytic infiltrate, extravasation of erythrocytes, and focal interface changes characterized DRESS cases. Less frequently, histopathology revealed the presence of necrotic keratinocytes; surprisingly, only in 2 cases the presence of rare dermal eosinophils was detected, even if all the patients had significant peripheral eosinophilia. A histopathological diagnosis of DRESS seems per se, according to our data, not feasible, since the main histopathological changes (interface changes, superficial perivascular dermatitis, focal spongiosis, lichenoid infiltrate, rare presence of necrotic keratinocytes) can be interpreted generically as a drug induced dermatitis. The above mentioned histopathological changes, however, when associated with clinical information on cutaneous and systemic involvement of the patient, allow the pathologist or the dermatopathologist to make a diagnosis of DRESS with a reliable margin of certainty.
Collapse
Affiliation(s)
- G Borroni
- Department of Clinical‑Surgical, Diagnostic and Pediatric Sciences Dermatology Section, University of Pavia Foundation IRCCS Policlinico San Matteo, Pavia, Italy -
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Montaldo P, Rosso R, Chello G, Giliberti P. Cardiac troponin I concentrations as a marker of neurodevelopmental outcome at 18 months in newborns with perinatal asphyxia. J Perinatol 2014; 34:292-5. [PMID: 24480903 DOI: 10.1038/jp.2014.1] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2013] [Revised: 12/26/2013] [Accepted: 12/31/2013] [Indexed: 12/30/2022]
Abstract
OBJECTIVE To investigate whether creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI) can be used to predict neurodevelopmental outcome at 18 months in infants with perinatal asphyxia (PA). The diagnostic value of cTnI to assess myocardial dysfunction was considered as well. STUDY DESIGN Retrospective study of 178 neonates admitted with PA. cTnI concentrations measured within 12 h of birth were compared with medium-term outcome assessed with the Bayley Scales of Infant Development. cTnI concentrations measured within 12 h of birth were compared with clinical grade of hypoxic-ischemic encephalopathy (HIE) and with duration of inotropic support. Two-dimensional Doppler and color Doppler findings were recorded. Fractional shortening, tricuspid and mitral regurgitation were evaluated. RESULT A statistically significant correlation between cTnI concentration and BSID-II score was found (mental development index r -0.69, P<0.05 and psychomotor development index r -0.39, P<0.05). There was no statistically significant correlation between CK-MB and BSID-II score (P>0.05).Serum cTnI concentrations and duration of inotropic support were significantly greater with increasing severity of PA. cTnI was negatively correlated with fraction shortening (r -0.64; P<0.05). The severity of tricuspid regurgitation was correlated with the cTnI concentration (r 0.61; P<0.05). CONCLUSION In asphyxiated neonates, cTnI concentrations within 12 h of birth correlate with medium-term outcome. Early cTnI concentration correlates with severity of HIE, myocardial dysfunction and with Bayley II scores at 18 months.
Collapse
Affiliation(s)
- P Montaldo
- Department of Pediatrics, Second University of Naples, Naples, Italy
| | - R Rosso
- Department of Neonatal Intensive Care, Monaldi Hospital, Naples, Italy
| | - G Chello
- Department of Neonatal Intensive Care, Monaldi Hospital, Naples, Italy
| | - P Giliberti
- Department of Neonatal Intensive Care, Monaldi Hospital, Naples, Italy
| |
Collapse
|
29
|
|
30
|
Prinapori R, Rosso R, Di Biagio A, Nicolini L, Giacobbe DR, De Hoffer L, Grignolo S, De Terlizzi F, Vignolo M, Borderi M, Martelli G, Calza L, Viale P, Vescini F, Viscoli C. Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? New Microbiol 2013; 36:345-351. [PMID: 24177296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/18/2012] [Accepted: 07/27/2013] [Indexed: 06/02/2023]
Abstract
This study estimated the prevalence of bone pathologies in a cohort of HIV-infected women in comparison with a cohort of HIV-negative women. Bone mineral density was measured by phalangeal quantitative ultrasound (AD-SoS: amplitude- dependent speed of sound; UBPI: ultrasound bone profile index). Risk of fracture, expressed by UBPI, was considered for value <0.39. Comparisons between groups and multivariate analyses were carried out using an ANOVA model. Correlations were evaluated using the Pearson correlation coefficient. Osteopenia and osteoporosis were present in 34.4% and 2% of patients, respectively. UBPI was pathologic in 5.7%. In a multivariate linear regression model significant correlations were found between AD-SoS z-score, duration of HIV-infection and BMI value. We also compared our cohort with 499 HIV-negative women as a historical control group of healthy subjects. AdSoS (2100 versus 2070 m/s) and UBPI (0.89 versus 0.74) were lower in HIV-infected women (p<0.001). Significant differences were also found in T-score values (p = 0.0013). These data show a high prevalence of bone diseases in women with HIV infection, correlated with duration of HIV-infection and BMI values. This non-invasive technique opens up new interesting perspectives, suggesting a possible use for bone mass screening in HIV-infected women.
Collapse
Affiliation(s)
- Roberta Prinapori
- Department of Internal Medicine and Infectious Diseases, IRCCS A.O.U. San Martino-IST, Genoa, Italy; 2Medical Office, IGEA s.r.l., Modena, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Lupi A, Porto I, Rognoni A, Secco GG, Lazzero M, Rossi L, Rosso R, Cristallini J, Nardi F, Bongo AS. Clinical and biomechanical behavior of a platinum-cromium stent platform in a large all-comers single centre PCI population: insights from the Novara-PROMETEUS registry. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
32
|
Grassi S, Rosso R, Tomasini C, Pezzini C, Merlino M, Borroni G. Post-surgical lipophagic panniculitis: a specific model of traumatic panniculitis and new histopathological findings. GIORN ITAL DERMAT V 2013; 148:435-441. [PMID: 23900165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Aim of this work was to define the histopathological features of post-surgical panniculitis. Dermal and hypodermal changes will be analyzed in detail, to understand the cascade of events that characterize the tissue response to surgical trauma. Cutaneous re-excision specimens of cases of basal cell carcinoma, squamous cell carcinoma, and melanoma consecutively seen from January 1, 2011 to June 30, 2011 at the Department of Dermatology, University of Pavia, were included in this study. Only the cases in which the first surgical procedure included the subcutaneous fat, were considered. In addition, the time elapsed from the first surgical procedure and the re-excision had to be included in a period of time from one to three months. All the specimens were stained with hematoxylin and eosin. Thirty cutaneous re-excision specimens were studied. Histopathologic examination revealed changes of epidermis, ranging from slight atrophy to moderate hyperplasia. In two cases focal ulceration was seen, with transfollicular elimination of foreign body material. The main dermal changes observed were the: 1) scar with well defined vertical orientation along the dermal suture line; 2) rounded cicatricial areas with radial branching septa of scarring tissue; 3) foreign body granuloma formation; 4) alignment of hystiocytes at the dermo-hypodermal border; 5) traumatic neuromas. The subcutaneous fat changes included: 1) lobular panniculitis with consistent presence of foam cells; 2) striking anisocytosis with pseudocystic degeneration and necrosis of adipocytes; 3) eritrocyte extravasation, mainly at the dermo-hypodermal border; 4) deep seated phlebitis. Post-surgical panniculitis is a lobular foam cell panniculitis characterized by simultaneous dermal and hypodermal changes, expression of the multi-faceted tissue response to a surgical trauma. This type of peculiar lipophagic response puts post-surgical panniculitis into the wider chapter of lipophage tissue response seen in atherosclerosis, glomerulosclerosis and some infectious models such as Mycobacterium tuberculosis and Chlamydia pneumoniae infections. Furthermore it may be seen as a reliable and convenient model for laboratory investigation on foam cell tissue response.
Collapse
Affiliation(s)
- S Grassi
- Department of Clinical and Surgical Diagnostic and Pediatric Sciences, Dermatology Clinic University of Pavia IRCCS Fondazione Policlinico San Matteo, Pavia, Italy -
| | | | | | | | | | | |
Collapse
|
33
|
Borroni G, Brazzelli V, Fornara L, Rosso R, Paulli M, Tinelli C, Ciocca O. Clinical, Pathological and Immunohistochemical Effects of Arsenical-Ferruginous SPA Waters on Mild-To-Moderate Psoriatic Lesions: A Randomized Placebo-Controlled Study. Int J Immunopathol Pharmacol 2013; 26:495-501. [DOI: 10.1177/039463201302600223] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Thermalism and spa treatments are traditionally considered effective in a number of dermatologic inflammatory conditions, yet there is scarce evidence about spring water effectiveness on psoriasis in a daily setting. We enrolled 34 patients with mild-to-moderate psoriasis in a double-blind, randomized, placebo-contralaterally-controlled trial, to evaluate Levico and Vetriolo arsenical-ferruginous water effectiveness on psoriatic lesions by daily 20-minute wet packing for 12 consecutive days. Clinical, histopathologic and immunohistochemical parameters were considered. A statistically significant difference between spa water-treated lesions and placebo-treated lesions in the same patients was demonstrated for histopathologic and immunohistochemical parameters. Since iron ions have an antiproliferative effect on epithelia, and magnesium ions have an anti-inflammatory effect, Levico and Vetriolo water effectiveness on psoriasis could be addressed to their content of these ions.
Collapse
Affiliation(s)
- G. Borroni
- Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - V. Brazzelli
- Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - L. Fornara
- Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - R. Rosso
- Anatomic Pathology Section, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - M. Paulli
- Anatomic Pathology Section, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - C. Tinelli
- Scientific Direction, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - O. Ciocca
- Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| |
Collapse
|
34
|
Toma S, Melioli G, Palumbo R, Rosso R. Recombinant interleukin-2 and interferon-alpha-2a in pretreated advanced soft-tissue sarcomas. Int J Oncol 2012; 2:997-1001. [PMID: 21573659 DOI: 10.3892/ijo.2.6.997] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Fourteen patients with advanced soft tissue sarcomas (STS), all pre-treated with one or more chemotherapy (CT) lines, entered an outpatient phase 11 study in which subcutaneous recombinant Interleukin-2 (rIL-2) and intramuscular recombinant alpha-2a-interferon (r-alphaIFN) were concomitantly administered. Both the cytokines were given for 5 days/week for 3 consecutive weeks followed by a 2 weeks period during which only r-alphaIFN was administered. r-alphaIFN was provided at a dose of 3 x 10(6) International Units (IU), while rIL-2 was given at a dosage of 6 x 10(6)/m2/day IU (in 2 subcutaneous injections), starting from 2 x 10(6)/m2/day IU in the first week and progressively increasing to 4 and 6 x 10(6)/m2/day IU in the second and third weeks; in 4 patients the dose of 8 x 10(6)/m2/day IU was reached. Toxicity was moderate and correlated with rIL-2 dose; main side effects included changes in liver functionality tests (14/14), fever (13/14), fatigue (13/14), nausea and vomiting (9/14). In all 11 patients evaluable for response, stable disease (SD) was observed (duration 4-43 weeks; median 9 weeks); the median survival from the starting treatment was 18 weeks (range 10-52). In all treated patients, an immunological monitoring was performed: an increase in percentage (from 10 to 74%) and in absolute number (from 400 to 4.500 cells/mm3) of CD16+ lymphocytes (NK cells) was observed in the majority of cases. Our data indicate that this regimen can be administered in pre-treated and severely immunocompromised patients with minimal to moderate toxicity on ambulatory and home bases, with acceptable clinical results.
Collapse
Affiliation(s)
- S Toma
- UNIV GENOA,IST ONCOL CLIN & SPERIMENTALE,I-16126 GENOA,ITALY
| | | | | | | |
Collapse
|
35
|
Panetella F, Posabella A, Galetti K, Giovannacci L, Gyr T, Rosso R. M254 A RARE CASE OF GIANT OVARIAN CYST. Int J Gynaecol Obstet 2012. [DOI: 10.1016/s0020-7292(12)61446-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Van Den Berg JC, Pedrotti M, Canevascini R, Chimchila Chevili S, Giovannacci L, Rosso R. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg (Torino) 2012; 53:215-222. [PMID: 22456644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
In-stent restenosis after endovascular treatment of stenotic and occlusive disease of the infrainguinal arteries is still a clinical challenge. In this paper an overview of the current status of drug-eluting balloon technology and results of clinical trials with drug-eluting balloon angioplasty is given. Furthermore a case series of 10 patients with in-stent restenosis that were treated with excimer laser angioplasty and drug eluting balloons is described. In this case series the mean lesion length treated was 115 mm, and the mean time to occurrence of restenosis after initial treatment was 7.2 months. At a mean follow-up (of all patients) of 7.6 months no target vessel revascularization was seen. In 7 patients that had Duplex and/or angiographic control (mean follow-up 7 months) no signs of neointimal hyperplasia were demonstrated. These short-term data compare favorable to results obtained with standard balloon angioplasty and cutting-balloon angioplasty. Long-term follow-up is necessary to define the role of combined excimer laser and drug-eluting balloon angioplasty in the treatment of in-stent restenosis further.
Collapse
Affiliation(s)
- J C Van Den Berg
- Service of Interventional Radiology, Ospedale Regionale di Lugano, Lugano, Switzerland.
| | | | | | | | | | | |
Collapse
|
37
|
Gregorini M, Castello M, Rampino T, Esposito P, Rosso R, Borroni G, Dal Canton A. Erythema nodosum in kidney transplant recipient: a rare complication of pneumonia treatment. Transpl Infect Dis 2012; 14:72-4. [PMID: 21466642 DOI: 10.1111/j.1399-3062.2011.00635.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Erythema nodosum (EN) is a cutaneous inflammatory reaction, usually reported in young women, but it is rarely observed among transplant patients. Localization in the lower extremities is typical, mostly involving the anterior surfaces of the legs. Several viral, bacterial, mycotic, and non-infectious etiologies, such as autommune disorders, drugs, inflammatory bowel diseases, sarcoidosis, pregnancy, and malignancies, have been found. We describe the case of a young woman kidney transplant recipient developing bilateral, erythematous, warm nodules localized on the anterior surface of her legs after antibiotic treatment for pneumonia with levofloxacin. Her immunosuppression was sirolimus and mycophenolate mofetil. EN was diagnosed by skin biopsy; microscopic examination showed septal panniculitis with granulomas. As a complete remission of the lesions was obtained in our patient after interruption of levofloxacin therapy, we suspect that levofloxacin was involved in the pathogenesis of EN. In fact, the management of EN is based on the treatment of underlying or associated conditions.
Collapse
Affiliation(s)
- M Gregorini
- Department of Nephrology, University of Pavia, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
| | | | | | | | | | | | | |
Collapse
|
38
|
Bassi E, Rosso R, Fiandrino G, De Filippi C. Sweet's syndrome with panniculitis. GIORN ITAL DERMAT V 2012; 147:127-128. [PMID: 22370578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
|
39
|
Rosso R, Munaro G, Salvetti O, Colantonio S, Ciancitto F. CHRONIOUS: an open, ubiquitous and adaptive chronic disease management platform for chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD) and renal insufficiency. Annu Int Conf IEEE Eng Med Biol Soc 2011; 2010:6850-3. [PMID: 21096301 DOI: 10.1109/iembs.2010.5626451] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
CHRONIOUS is an highly innovative Information and Communication Technologies (ICT) research Initiative that aspires to implement its vision for ubiquitous health and lifestyle monitoring. The 17 European project partners are strictly working together since February 2008 to realize and open platform to manage and monitor elderly patients with chronic diseases and many difficulties to reach hospital centers for routine controls. The testing activities will be done in Italy and Spain involving COPD (Chronic Obstructive Pulmonary Disease) and CKD (Chronic Kidney Disease) patients, these being widespread and highly expensive in terms of social and economic costs. Patients, equipped by wearable technologies and sensors and interacting with lifestyle interfaces, will be assisted by healthcare personnel able to check the health record and critical conditions through the Chronious platform data analysis and decision support system. Additionally, the new ontology based literature search engine will help the clinicians in the standardization of care delivery process. This paper is to present the main project objectives and its principal components from the intelligent system point of view.
Collapse
|
40
|
Belhassen B, Glick A, Rosso R, Michowitz Y, Viskin S. Atrioventricular block during radiofrequency catheter ablation of atrial flutter: incidence, mechanism, and clinical implications. Europace 2011; 13:1009-14. [DOI: 10.1093/europace/eur056] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Cefali P, Rosso R, Van Den Berg JC. Training of vascular surgeons by interventional radiologists. J Cardiovasc Surg (Torino) 2011; 52:57-62. [PMID: 21224811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
This paper will discuss the potential role of interventional radiologists in teaching of endovascular skills to vascular surgical trainees. Prerequisites and advantages of such a training will be discussed, as well as the secondary effect this kind of training program may have on developing multidisciplinary teams.
Collapse
Affiliation(s)
- P Cefali
- CDepartment of Vascular Surgery, Cliniche Humanitas-Gavazzeni, Bergamo, Italy
| | | | | |
Collapse
|
42
|
Rožič B, Tzitzios V, Karatairi E, Tkalec U, Nounesis G, Kutnjak Z, Cordoyiannis G, Rosso R, Virga EG, Muševič I, Kralj S. Theoretical and experimental study of the nanoparticle-driven blue phase stabilisation. Eur Phys J E Soft Matter 2011; 34:17. [PMID: 21340674 DOI: 10.1140/epje/i2011-11017-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2010] [Accepted: 01/17/2011] [Indexed: 05/30/2023]
Abstract
We have studied theoretically and experimentally the effects of various types of nanoparticles (NPs) on the temperature stability range [Formula: see text] T (BP) of liquid-crystalline (LC) blue phases. Using a mesoscopic Landau-de Gennes type approach we obtain that the defect core replacement (DCR) mechanism yields in the diluted regime [Formula: see text] T (BP)(x) [Formula: see text] 1/(1 - xb) , where x stands for the concentration of NPs and b is a constant. Our calculations suggest that the DCR mechanism is efficient if a local NP environment resembles the core structure of disclinations, which represent the characteristic property of BP structures. These predictions are in line with high-resolution ac calorimetry and optical polarising microscopy experiments using the CE8 LC and CdSe or aerosil NPs. In mixtures with CdSe NPs of 3.5nm diameter and hydrophobic coating the BPIII stability range has been extended up to 20K. On the contrary, the effect of aerosil silica nanoparticles of 7.0nm diameter and hydrophilic coating is very weak.
Collapse
Affiliation(s)
- B Rožič
- Condensed Matter Physics Department, Jožef Stefan Institute, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Kumar S, Sutherland F, Heck P, Teh A, Lee G, Medi C, Rosso R, Wheeler M, Garg M, Morgan J, Sparks P. Mechanisms and Effects of Chronic Omega-3 Polyunsaturated Fatty Acid Supplementation on Human Atrial Electrical and Mechanical Function. Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
44
|
Esposito C, Grosjean F, Torreggiani M, Esposito V, Mangione F, Villa L, Sileno G, Rosso R, Serpieri N, Molinaro M, Fasoli G, Dal Canton A. Sirolimus prevents short-term renal changes induced by ischemia-reperfusion injury in rats. Am J Nephrol 2011; 33:239-49. [PMID: 21358177 DOI: 10.1159/000324577] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2010] [Accepted: 01/24/2011] [Indexed: 11/19/2022]
Abstract
BACKGROUND Ischemia-reperfusion (I/R) is present at various degrees in kidney transplants. I/R plays a major role in early function and long-term survival of renal allograft. The purpose of our study was to determine if immunosuppressants modulate I/R in a model that separates I/R from all immune responses. METHODS Sprague-Dawley rats with monolateral renal I/R received daily cyclosporine (A), tacrolimus (B), sirolimus (C) or saline (D). Sham-operated rats received saline (E). After 30 days, glomerular filtration rate for each kidney was measured by inulin clearance. Kidney injury was examined, and TGF-β, fibronectin and metalloproteases were evaluated by real-time PCR, Western blot and zymography. RESULTS Sirolimus, but not cyclosporine and tacrolimus, prevented a glomerular filtration rate decrease in I/R kidneys (403 ± 303 vs. 1,006 ± 484 μl/min, p < 0.05; 126 ± 170 vs. 567 ± 374 μl/min, p < 0.05; 633 ± 293 vs. 786 ± 255; A, B and C group, respectively, I/R vs. contralateral kidneys). Sirolimus reduced ED-1+ cell infiltrate, interstitial fibrosis and intimal thickening of small vessels observed in I/R kidneys of controls and calcineurin inhibitor-treated rats. Tacrolimus and cyclosporine increased fibronectin and TGF-β expression and matrix deposition. Only sirolimus increased metalloprotease activity. CONCLUSIONS Sirolimus but not calcineurin inhibitors prevented I/R-induced kidney injury.
Collapse
Affiliation(s)
- C Esposito
- Units of Nephrology, Dialysis and Transplantation, Policlinico San Matteo, University of Pavia, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, Vohra JK, Kumar S, Kalman JM. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2010; 22:137-41. [PMID: 20812937 DOI: 10.1111/j.1540-8167.2010.01885.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Pulmonary veins play an important role in triggering atrial fibrillation (AF). Pulmonary vein isolation (PVI) is an effective treatment for patients with paroxysmal AF. However, the late AF recurrence rate in long-term follow-up of circumferential PV antral isolation (PVAI) is not well documented. We sought to determine the time to recurrence of arrhythmia after PVAI, and long-term rates of sinus rhythm after circumferential PVAI. METHODS One hundred consecutive patients with a mean age of 54 ± 10 years, with paroxysmal AF who underwent PVAI procedure were analyzed. Isolation of pulmonary veins was based on an electrophysiological and anatomical approach, with a nonfluoroscopic navigation mapping system to guide antral PVI. Ablation endpoint was vein isolation confirmed with a circular mapping catheter at first and subsequent procedures. Clinical, ECG, and Holter follow-up was undertaken every 3 months in the first year postablation, every 6 months thereafter, with additional prolonged monitoring if symptoms were reported. Time to arrhythmia recurrence, and representing arrhythmias, were documented. RESULTS Isolation of all 4 veins was successful in 97% patients with 3.9 ± 0.3 veins isolated/patient. Follow-up after the last RF procedure was at a mean of 39 ± 10 months (range 21-66 months). After a single procedure, sinus rhythm was maintained at long-term follow-up in 49% patients without use of antiarrhythmic drugs (AADs). After repeat procedure, sinus rhythm was maintained in 57% patients without the use of AADs, and in 82% patients including patients with AADs. A total of 18 of 100 patients had 2 procedures and 4 of 100 patients had 3 procedures for recurrent AF/AT. Most (86%) AF/AT recurrences occurred ≤ 1 year after the first procedure. Mean time to recurrence was 6 ± 10 months. Kaplan-Meier analysis on antiarrhythmics showed AF free rate of 87% at 1 year and 80% at 4 years. There were no major complications. CONCLUSION PVAI is an effective strategy for the prevention of AF in the majority of patients with PAF. Maintenance of SR requires repeat procedure or continuation of AADs in a significant proportion of patients. After maintenance of sinus rhythm 1-year post-PVAI, a minority of patients will subsequently develop late recurrence of AF.
Collapse
Affiliation(s)
- C Medi
- Department of Cardiology, Royal Melbourne Hospital Department of Medicine, University of Melbourne, Melbourne, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Giaquinto C, Penazzato M, Rosso R, Bernardi S, Rampon O, Nasta P, Ammassari A, Antinori A, Badolato R, Castelli Gattinara G, d'Arminio Monforte A, De Martino M, De Rossi A, Di Gregorio P, Esposito S, Fatuzzo F, Fiore S, Franco A, Gabiano C, Galli L, Genovese O, Giacomet V, Giannattasio A, Gotta C, Guarino A, Martino A, Mazzotta F, Principi N, Regazzi MB, Rossi P, Russo R, Saitta M, Salvini F, Trotta S, Viganò A, Zuccotti G, Carosi G. Italian consensus statement on paediatric HIV infection. Infection 2010; 38:301-19. [PMID: 20514509 DOI: 10.1007/s15010-010-0020-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2009] [Accepted: 03/17/2010] [Indexed: 02/01/2023]
Abstract
The objective of this document is to identify and reinforce current recommendations concerning the management of HIV infection in infants and children in the context of good resource availability. All recommendations were graded according to the strength and quality of the evidence and were voted on by the 57 participants attending the first Italian Consensus on Paediatric HIV, held in Siracusa in 2008. Paediatricians and HIV/AIDS care specialists were requested to agree on different statements summarizing key issues in the management of paediatric HIV. The comprehensive approach on preventing mother-to-child transmission (PMTCT) has clearly reduced the number of children acquiring the infection in Italy. Although further reduction of MTCT should be attempted, efforts to personalize intervention to specific cases are now required in order to optimise the treatment and care of HIV-infected children. The prompt initiation of treatment and careful selection of first-line regimen, taking into consideration potency and tolerance, remain central. In addition, opportunistic infection prevention, adherence to treatment, and long-term psychosocial consequences are becoming increasingly relevant in the era of effective antiretroviral combination therapies (ART). The increasing proportion of infected children achieving adulthood highlights the need for multidisciplinary strategies to facilitate transition to adult care and maintain strategies specific to perinatally acquired HIV infection.
Collapse
Affiliation(s)
- C Giaquinto
- Dipartimento di Pediatria, Università degli Studi di Padova, Padova, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Giovannacci L, Cefali P, Rosso R, Van Den Berg JC. The surgical and endovascular management of deep venous thrombosis of the lower extremity. J Cardiovasc Surg (Torino) 2010; 51:343-354. [PMID: 20523284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
This paper will discuss the clinical sequelae of deep venous thrombosis of the lower extremity and will deal briefly with conservative therapy. The (endo)vascular modalities that are currently used will be described more in detail, and includes systemic thrombolysis, surgical thrombectomy, catheter directed thrombolysis and other catheter based therapies like ultrasound assisted thrombolysis, pharmacomechanical thrombolysis and percutaneous mechanical thrombectomy. Results, advantages and disadvantages of each technique will be dealt with.
Collapse
Affiliation(s)
- L Giovannacci
- Service of Vascular Surgery, Ospedale Regionale di Lugano, sede Civico, Lugano, Switzerland
| | | | | | | |
Collapse
|
48
|
Rosso R, Fenoglio D, Terranova MP, Lantieri F, Risso D, Pontali E, Setti M, Cossarizza A, Ravetti JL, Viscoli C, Kunkl A. Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths. Scand J Immunol 2010; 71:45-51. [PMID: 20017809 DOI: 10.1111/j.1365-3083.2009.02345.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Surrogate markers for monitoring immuno-virological discordant responders, in addition to plasma viral load and CD4 cells, are still lacking. We assessed the diagnostic utility of CD38 expression on CD8 T cell assay, alone or in association with lymphocyte proliferation to mycotic antigens, in evaluating antiretroviral response. 28 vertically HIV-infected youths, 21 HAART- and seven 2 nucleotide reverse transcriptase inhibitors-treated, were enrolled in a retrospective study. Responders (57.1%) and non-responders (42.9%) to stable antiretroviral therapy for a minimum of 6 months, on the basis of viral load and CD4 T cells, comprehensively evaluated by CD38 expression on CD8 T lymphocytes [measured as CD38 antibody bound per CD8 T cell (CD38 ABC) and %CD38+ of total CD8 T cells (%CD38/CD8)] and lymphocyte proliferation to P. jiroveci, C. albicans, C. neoformans, A. fumigatus at a single time point after treatment, were selected. CD38 expression > or =2401 CD38 ABC and > or =85% CD38/CD8 cut-off points, accurately discriminates responders versus non-responders, both measures resulting in 75.0% (CI 42.8-94.5) sensitivity (identification of non-responder) and 93.8% (CI 69.8-99.8) specificity (identification of responder), when considered as single assays. The association '> or =2401 CD38 ABC or > or =85% CD38/CD8' improved sensitivity to 83.3% (CI 51.6-97.9), while the association '<2401 CD38ABC (or <85% CD38/CD8) and lymphoproliferative response positive to > or =2 tested organisms' improved specificity to 100% (CI 79.4-100). In conclusions, CD38 expression and mycotic antigen-specific T-cell proliferation may be used as additional parameters to existing criteria to evaluate antiretroviral response in immuno-virological discordant patients.
Collapse
Affiliation(s)
- R Rosso
- Infectious Diseases Clinic, University of Genoa, San Martino Hospital, Genova, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Lee G, Sparks P, Morton J, Kistler P, Vohra J, Medi C, Rosso R, Teh A, Halloran K, Kalman J. The Safety and Utility of Routine General Anesthesia and Trans-esophageal Echocardiography in AF Ablation. Experience from 500 Consecutive Procedures. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
50
|
Lee G, Sparks P, Morton J, Kistler P, Vohra J, Medi C, Rosso R, Teh A, Halloran K, Kalman J. Very Low Risk of Major Complications Associated with Antral Pulmonary Vein Isolation for Atrial Fibrillation. Results of 500 Consecutive Ablation Procedures in Young Patients with Low Prevalence of SHD from a Single Centre. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|